Início/Ações/RLMD

RLMD

USD

Relmada Therapeutics Inc. Common Stock

$2.770+0.560 (25.339%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$2.210

Máximo

$2.810

Mínimo

$2.190

Volume

0.98M

Fundamentos da empresa

Capitalização de mercado

91.9M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.74M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.24Atual $2.770Máximo $3.5

Notícias relacionadas

4/11/2025 · 12:09

GlobeNewswire

Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and

Ver mais

Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

4/11/2025 · 12:01

GlobeNewswire

Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer

Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized

Ver mais